Finance

Lists
3164:TPE
GenMont Biotech Inc
NT$16,60
+1,84%
(+0,30) 1D
29 Sep., 13:30:06 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 3164...
Open
NT$16,40
High
NT$16,65
Low
NT$16,40
Mkt. cap
1,43 mjd
Avg. vol.
21,35 k
Volume
102,56 k
Dividend
4,82%
Quarterly dividend
NT$0,20
Ex-dividend date
08 Apr. 2026
P/E ratio
20,71
52-wk high
NT$19,75
52-wk low
NT$15,35
EPS
NT$0,80
Shares outstanding
88,91 m
No. of employees
147
Open
NT$16,40
High
NT$16,65
Low
NT$16,40
Mkt. cap
1,43 mjd
Avg. vol.
21,35 k
Volume
102,56 k
Dividend
4,82%
Quarterly dividend
NT$0,20
Ex-dividend date
08 Apr. 2026
P/E ratio
20,71
52-wk high
NT$19,75
52-wk low
NT$15,35
EPS
NT$0,80
Shares outstanding
88,91 m
No. of employees
147
About GenMont Biotech Inc
CEO-
Employees147
Founded2000
Headquarters-
Sector-
Websitegenmont.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
88,90 m
100,70 m
89,17 m
103,33 m
Cost of goods sold
33,41 m
38,03 m
40,95 m
42,22 m
Cost of revenue
33,41 m
38,03 m
40,95 m
42,22 m
Research and development expenses
11,02 m
11,62 m
10,48 m
11,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,01 m
38,04 m
35,28 m
36,36 m
Operating expense
46,77 m
50,91 m
55,40 m
46,42 m
Total operating expenses
80,18 m
88,94 m
96,35 m
88,64 m
Operating income
8,72 m
11,76 m
-7,18 m
14,70 m
Other non operating income
586,00 k
374,00 k
61,00 k
81,00 k
EBT including unusual items
28,68 m
29,47 m
3,38 m
19,56 m
EBT excluding unusual items
23,39 m
29,47 m
3,38 m
19,56 m
Income tax expense
6,38 m
7,16 m
1,58 m
6,70 m
Effective tax rate
22,26%
24,31%
46,60%
34,27%
Other operating expenses
-
-
-
-
Net income
24,68 m
24,80 m
4,15 m
15,54 m
Net profit margin
27,76%
24,62%
4,65%
15,04%
Earnings per share
-
-
-
-
Interest and investment income
1,74 m
1,55 m
1,62 m
1,69 m
Interest expense
-953,00 k
-900,00 k
-937,00 k
-1,03 m
Net interest expenses
784,00 k
651,00 k
685,00 k
654,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
24,07 m
27,26 m
9,11 m
31,09 m
Gain or loss from assets sale
-
1,00 k
-
7,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme